All In Biotech

Free tool

FAERS Monitor: Nuplazid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207318 or its brand name (Nuplazid, Pimavanserin Tartrate). Reports on generic versions are filed under their own applications.

Reports

57,532

Serious

29,715

52% of reports

Hospitalization

9,470

Death reported

14,647

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hallucination13,278
  • death11,261
  • drug ineffective6,630
  • confusional state4,448
  • product dose omission issue4,364
  • fall4,197
  • delusion2,852
  • condition aggravated2,605
  • hallucination, visual2,413
  • parkinson^s disease2,350
  • gait disturbance2,289
  • urinary tract infection1,923
  • somnolence1,793
  • adverse drug reaction1,704
  • peripheral swelling1,697

Reports by year received

View as table
YearReports
20152
20161,269
20174,548
20184,467
20192,606
20205,917
20214,703
20224,300
20234,501
20247,184
202510,493
20267,542

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,996,627 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
delusionSignal2,85282.078.8186,417
hallucinationSignal13,27878.076.7834,072
hallucination, visualSignal2,41347.045.196,355
confusional stateSignal4,44810.310.036,680
adverse drug reactionSignal1,7047.16.78,711
product dose omission issueSignal4,3645.55.316,015
deathSignal11,2614.84.735,176
fallSignal4,1974.74.512,086
gait disturbanceSignal2,2894.44.26,021
urinary tract infectionSignal1,9234.24.04,593
peripheral swellingSignal1,6974.13.93,897
somnolenceSignal1,7933.33.12,834
condition aggravatedSignal2,6053.23.03,845
drug ineffective6,6301.81.82,715
parkinson^s disease2,3500.00.0857,375

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.